Clinical trials
Recruiting Neoplasms by Site trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 12 |
| 2024 | 5 |
| 2025 | 13 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Research UK | 7 |
| Astellas Pharma Global Development, Inc. | 2 |
| AstraZeneca | 2 |
| Eli Lilly and Company | 2 |
| Massachusetts General Hospital | 2 |
| Pfizer | 2 |
| Alterome Therapeutics, Inc. | 1 |
| Boston Scientific Corporation | 1 |
| Cerenome | 1 |
| Cogent Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms by Site | 49 |
| Neoplasms | 45 |
| Neoplasms by Histologic Type | 18 |
| Lung Neoplasms | 14 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Hematologic Neoplasms | 10 |
| Lung Diseases | 10 |
| Neoplasm Metastasis | 10 |
| Respiratory Tract Diseases | 10 |
| Respiratory Tract Neoplasms | 10 |
Trials
Showing 76 to 49 of 49. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.